glp 1 side pain GLP-1 Medications: Everything You Need to Know GLP-1 side effect management: Preventing

Analysts believe the risk of NAION is unlikely to have a significant impact on prescriptions unless Ozempic is proven to be uniquely susceptible to this risk compared to other GLP-1 drugs

SGLT-2 inhibitors: the gap seems to be leveling off

Ongoing research is ongoing to explore broader therapeutic applications

References & Resources FDA Basaglar Prescribing Information FDA Ozempic Prescribing Information American Diabetes Association Standards of Care 2026 Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice

Larger, more rigorously designed studies are needed before these findings alter clinical practice, she said